+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 0 - 18Years
All Genders
ID07684885

Accuracy Evaluation of Non-Invasive Blood Pressure Devices in Newborns and Children Up to 18 Years

Led by GE Healthcare · Updated on 2026-07-06

110

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to validate the accuracy of new non-invasive blood pressure NIBP measurement methods in newborns and children up to 18 years old. The study follows established international safety and performance standards for automated blood pressure devices to ensure reliable clinical data collection in pediatric populations. Participants will have blood pressure measured using the NIBP Standard Parameter Module with the SuperSTAT algorithm. Children with upper-arm circumferences in overlapping ranges will be randomized to receive measurements with either a Child cuff or Small Adult cuff, or a Small Adult cuff or Adult cuff. Those in non-overlapping ranges will receive the appropriate cuff without randomization. The study collects simultaneous invasive blood pressure waveforms as part of the evaluation. During the study, participants must have an arterial line as part of their standard care and remain in the unit for up to 12 hours while measurements are taken. Researchers will assess the accuracy of the NIBP measurements compared to invasive blood pressure recordings. The study focuses on safety, device performance, and adherence to clinical standards, with the goal of improving NIBP technology for children and neonates.

CONDITIONS

Brief Title

NIBP Study for Neonate and Pediatric Subject Populations

Research Team

O

Otto Rahkonen Principal Invastigator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here